Safety and Immunogenicity Study of Venezuelan Equine Encephalomyelitis (VEE) Vaccine as Booster Vaccine in Adults

NCT03531242 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

500

Enrollment

FED

Sponsor class

Conditions

Venezuelan Equine Encephalomyelitis

Interventions

BIOLOGICAL: 0.5 mL Inactivated, Dried, C-84, TSI-GSD 205, Lot 7, Run 1

Sponsor

U.S. Army Medical Research and Development Command